Utrecht, Netherlands · Founded 2018 · Privately Held (backing)
Developer of biopharmaceutical drugs intended to serve doctors and healthcare professionals to improve the treatment of thrombosis. TargED Biopharmaceuticals is based in Utrecht, Netherlands and was founded in 2018. Its last reported valuation was $50 million in Dec 2025. It has raised $72.2 million.
Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$72.2M
Last round
—
Cap table — not yet on record
TargED Biopharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of TargED Biopharmaceuticals with a free account
·The complete investor list: 17 names
·Watch TargED Biopharmaceuticals: the Monday email on marks, rounds and moves
